Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good morning, and welcome ...

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology ...

Good morning, and welcome to the Wave Life Sciences Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen only mode. As a reminder, this call is being ...

Despite a net loss, WAVE Life Sciences Ltd (WVE) showcases promising clinical progress and a strengthened financial position ...

Analyst Joon Lee of Truist Financial maintained a Buy rating on Wave Life Sciences (WVE – Research Report), with a price target of ...

In other recent news, WAVE Life Sciences has seen a flurry of activity with promising data from its Duchenne muscular dystrophy (DMD) drug candidate, WVE-N531, leading to raised share targets by B ...

The company’s candidate, WVE-N531, a treatment specifically designed for patients with a mutation in exon 53 of the dystrophin gene. It is a type of gene therapy that aims to restore the ...

Apart from the AATD indication, there are several other candidates like WVE-N531, WVE-003 and WVE-007 in Wave Life Sciences’ pipeline, which are being developed for rare and prevalent diseases ...

The biotechnology company reported promising data from its Duchenne muscular dystrophy (DMD) drug candidate, WVE-N531, which led to raised share targets by B.Riley and JPMorgan. Analysts from B ...

Wave Life Sciences has also reported promising data from its Duchenne muscular dystrophy (DMD) drug candidate, WVE-N531, leading to raised share targets by B.Riley and JPMorgan (NYSE:JPM). Analysts ...

The biotechnology company reported promising data from its Duchenne muscular dystrophy (DMD) drug candidate, WVE-N531, which led to raised share targets by B.Riley and JPMorgan (NYSE:JPM). Analysts ...

Phase 2 results with Wave Life Sciences' Duchenne muscular dystrophy candidate WVE-N531 pushed the company's share price to its highest level in a year and could lead to discussions with ...